Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0015 Transporter Info | ||||
| Gene Name | ABCC4 | ||||
| Transporter Name | Multidrug resistance-associated protein 4 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Cefadroxil Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 47965 | ||||
| Docking Score | -10.769 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C16H17N3O5S | ||||
| Molecular Weight | 363.4 | ||||
| Canonical SMILES |
CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)SC1)C(=O)O
|
||||
| InChI |
InChI=1S/C16H17N3O5S/c1-7-6-25-15-11(14(22)19(15)12(7)16(23)24)18-13(21)10(17)8-2-4-9(20)5-3-8/h2-5,10-11,15,20H,6,17H2,1H3,(H,18,21)(H,23,24)/t10-,11-,15-/m1/s1
|
||||
| InChIKey | BOEGTKLJZSQCCD-UEKVPHQBSA-N | ||||
| Pharmaceutical Properties | Xlogp | -2.1 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 7 | ||
| Xenobiotic Name | Candesartan Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 2541 | ||||
| Docking Score | -10.345 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C24H20N6O3 | ||||
| Molecular Weight | 440.5 | ||||
| Canonical SMILES |
CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
|
||||
| InChI |
InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)
|
||||
| InChIKey | HTQMVQVXFRQIKW-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 4.1 | Rotatable Bond Count | 7 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | ||
| Xenobiotic Name | Telmisartan Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 65999 | ||||
| Docking Score | -10.214 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C33H30N4O2 | ||||
| Molecular Weight | 514.6 | ||||
| Canonical SMILES |
CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
|
||||
| InChI |
InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)
|
||||
| InChIKey | RMMXLENWKUUMAY-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 6.9 | Rotatable Bond Count | 7 | |
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.